FDA Confers GRAS Status to Monsanto’s Vistive® Soybeans
[The purpose of this product is to reduce saturated fat and eliminate trans fat in processed foods containing soybean oil. Please see #msg-43578079 for background.]
›Milestone Enables Food Companies to Develop and Test Foods Containing Oil from Vistive® Gold Soybeans
May 18, 2010, 10:09 am EDT
ST. LOUIS, May 18, 2010 /PRNewswire-FirstCall/ -- In keeping with a commitment to provide new options for agriculture and a more health-conscious public, Monsanto Company (NYSE:MON) announced today that the company has reached an important regulatory milestone that will advance the development of foods with reduced saturated fat and reduced or no trans fats.
The U.S. Food and Drug Administration (FDA) issued a response letter to Monsanto's Generally Recognized as Safe (GRAS) notification. The FDA's letter supports the use of oil from Vistive Gold soybeans under the intended conditions of use.
The GRAS status enables food companies to develop and test foods containing this nutritionally improved soybean oil, which is an important step toward offering consumers the benefit from this oil in a variety of food products, such as French fries or crackers.
"This product could offer farmers and the food industry an opportunity to help meet a growing demand for healthier foods," said Roy Fuchs, Monsanto's global technology lead for oilseeds. "Vistive Gold provides a glimpse into the next-generation of soybean products that can bring direct health benefits to consumers. We also expect farmers to benefit from the premium pricing opportunity the market is likely to offer for this oil once it's commercialized."
The company has completed U.S. regulatory submissions to the U.S. Department of Agriculture (USDA) and FDA, and has made numerous regulatory submissions to the appropriate regulatory agencies around the world for the product. Upon completion of the necessary regulatory processes, food companies will be able to purchase this new food oil and sell healthier food prepared with this oil.
"I get really excited about the possibility of growing soybeans like Vistive Gold," said Victor Bohuslavsky, QUALISOY vice chairman and soybean farmer from Nebraska. "Oil from these beans can help food companies meet their reduced trans and saturated fat goals. It's also got the flexibility to be used alone or with other oils to optimize cost and taste."
This second-generation product builds on Monsanto's existing Vistive soybeans by providing food companies with a more stable soybean oil for frying, cracker and snack food production and baking applications that can lower levels of saturated fat and eliminates trans fats. Research has shown that a diet low in saturated fats and trans fats promotes heart health. In addition, application studies show that products fried in the new oil maintain optimum flavor quality.
"A product like Vistive Gold is exciting because it may offer a healthier option to allow people to enjoy some of their favorite foods without the worry of consuming too much saturated or trans fat," said Nutrition Communication Consultant Connie Diekman, R.D., who is past president of the American Dietetic Association. "Small steps toward healthier eating can add up and really make a positive difference."
Monsanto is actively seeking food application partnerships with companies interested in delivering food products to consumers with this improved oil.‹
[This is a Morgan Joseph sell-side report that was published two days ago, before today’s news of MON’s market-share gain in South America (#msg-50376492). Coincidence? I dunno.]
›By Morgan Joseph ($54.61, May 17, 2010) Analyst: Charles E. Mitchell Rentschler
Contrary to a lot of the press the company has been receiving, we believe that Monsanto (ticker: MON) is making some solid progress, and see weakness as a buying opportunity, although we are lowering our target price to $65 from $90.
While in the U.S. the company may have lost a point or two in share of soybean seeds this year, Monsanto has maintained its position year-over-year in corn seeds at 36%.
We think that American farmers value Monsanto's technology, and that most are giving the company the opportunity to get its prices right. Then, too, bear in mind that a large part of seed-selling hinges on the personal relationship between the farmer and the Monsanto salesman that typically can offer very helpful horticultural advice. Indicating that farmers aren't backing away from it, Monsanto got growers last year to plant three million acres of its new eight-traited SmartStax corn seed and to raise six million acres of its new Roundup Ready 2 Yield soybean seeds, largest ever, respectively, for new-product launches of corn and bean seeds.[Still, these acreages were ~25% below MON’s original expectations, stemming in part from MON’s overpricing.]It expects the acreage for these new products to reach 15 million to 17 million in 2011.
Meanwhile, the company is frontally dealing with the reality of reinvigorated competition from China in its glyphosate [Roundup] business. Monsanto is downsizing this business to generate annual-gross profits of about $600 million, or on a par with fiscal 2006 levels, roughly one-third of the returns it enjoyed in fiscal 2008 and 2009, when it took far too much advantage of its Asian counterparts' missteps, in our opinion.
Monsanto estimates it can grow its earnings at a 15% annual clip, for the time being[the actual guidance is 13-17%]. While Monsanto's next "blockbuster" product launches are a couple of years out, demand in the meantime for its corn and soybean seeds should remain very strong, we predict.
Ethanol is a huge customer, of course, for U.S, maize[however, an offsetting trend is the HFCS-free junk food has become a fad], and exports of beans and corn from the Americas, particularly to Asia, continue to grow. China, in fact, is just starting to import corn, albeit tentatively.[MON does not currently derive material revenue from China, but that could change.]
We would note, too, that U.S. farmers appear to be raising the intensity of corn-seed/acre by 2%-3% per year[i.e. the individual plants are being positioned closer together thanks to equipment from such companies as DE that uses GPS and other high-tech features]. Monsanto's new-product pipeline, though, should start bubbling again in earnest in fiscal 2012[especially if SmartStax Refuge-in-a-Bag corn is approved in time for a 2012 US launch—see below].
The company, by then, should have EPA-approval for its 5% "refuge-in-a-bag" product[#msg-48335964]. The "refuge," or non-insect-protected seeds randomly included in each sack of SmartStax so that the farmer does not have to sew them separately, and time-consumingly [LOL—is this a word?]Farmers that we know speak highly of this concept[no kidding].
About then[i.e. 2012], we expect Monsanto to introduce its Vistive Gold soybeans that offer a sustainable, land-based source of omega-3 fatty acid as found in, and every bit as beneficial for people as, fish oil[#msg-50378314]. While becoming the very first genetically-modified seed-product designed for consumption by people, Vistive Gold oil would be a processed product -- i.e., not directly consumed by humans. We can envision enormous demand for this product.
Excitingly, moreover, in a couple of years Monsanto expects to market its very first soybean seed with two genes (its current Roundup Ready 2 Yield consists of a single gene making it tolerant of glyphosate and a yield "benefit," or booster). The new offering, dubbed, Insect-protected + Roundup Ready 2 Yield, will possess a second, insect-resistant gene and make its debut in Brazil[this product would be “overdesigned” for the US], where, because of the humid climate, insects are a huge problem and where the company believes it can quickly populate 50 million acres. We figure, also, that the company will have begun selling SmartStax corn seed in South America.
While we would expect product introductions like these to accelerate Monsanto's growth, we think the mid-part of this decade should see the launch of products that are probably even more spectacular: corn that's drought resistant[#msg-41324910], corn that needs a lot less nitrogen than typical / thrives on more nitrogen than typical, and soybeans tolerant of dicamba herbicide (in addition to glyphosate).
We are really excited, also, about the prospects for Monsanto's vegetable seeds. Revenue of this business, which has gross margins just over 60%, soon will exceed $1 billion a year, all accomplished by breeding, none stemming from genetic-modification.
It is impossible for us to dollarize the increment to gross profit from each and all of the above, but we believe collectively they will provide Monsanto with the ability to start growing rapidly again, well above the 15% annual rate it is projecting for the time being.
In short, we see a lot to like in Monsanto shares and would recommend investors buy them on weakness caused either by specific adverse publicity[there’s certainly no shortage of that—see #msg-48939741] or by general market conditions.‹
Market Data 
Markets 
AI
